Epigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancer.
Kiyoshi MisawaDaiki MochizukiAtsushi ImaiYuki MisawaShiori EndoMasato MimaHideya KawasakiThomas E CareyTakeharu KanazawaPublished in: Clinical epigenetics (2017)
This study suggests that CpG hypermethylation is a likely mechanism of SALL3 gene inactivation, supporting the hypothesis that the SALL3 gene may play a role in the tumorigenesis of HNSCC and may serve as an important biomarker.